Durata Therap (DRTX) Posts Wider than Expected Q3 Loss of $1.47/Share

Durata Therap (NASDAQ: DRTX) reported Q3 EPS of ($1.47), $0.47 worse than the analyst estimate of ($1.00).

For earnings history and earnings-related data on Durata Therap (DRTX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Dare Bioscience (DARE) Tops Q2 EPS by 11c